Geriatrics News

Members of the Advisory Committee on Immunization Practices, or ACIP, voted 8-7 today to recommend the recently approved herpes zoster vaccine, Shingrix, over the only other FDA-approved vaccine, Zostavax.

GlaxoSmithKline recently announced that the FDA has approved the company’s herpes zoster vaccine, Shingrix, for adults aged 50 years and older.

Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on Healio.com/Dermatology.

Study findings that pathologists had lower levels of accuracy and reproducibility in diagnosing some melanomas when compared with other types of melanoma was among recent developments reported on Healio.com/Dermatology.

Bullous pemphigoid demonstrated some association with hematologic malignancy despite showing no association with overall malignancy.

The FDA’s approval of Baxdela for treating acute bacterial skin and skin structure infections was among the top read articles of the past week on Healio.com/Dermatology.

Emergency department visits and total cost associated with herpes zoster increased between 2006 and 2013, driven by an increased number of visits by patients aged 20 to 59 years, according to recently published study results in JAMA Dermatology.

Findings that tildrakizumab showed efficacy as treatment for patients with moderate-to-severe chronic plaque psoriasis compared with placebo or Enbrel was among the top read articles of the past week on Healio.com/Dermatology.

Case report study results that Keytruda therapy was associated with eruptive keratoacanthomas in three patients with metastatic squamous cell carcinoma or metastatic melanoma was among recent developments reported on Healio.com/Dermatology.

Primary care-based skin cancer training and screening is feasible, and may improve primary care physician diagnostic accuracy, according to recently published study results in JAMA Dermatology.